Skip to main content
Log in

Bladder carcinoma following cyclophosphamide therapy

A case report

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Cyclophosphamide was introduced in 1958 in an effort to minimize the side effects of nitrogen mustard [2]. Cyclophosphamide (Cytoxan, Endoxan) is an alkylating agent which has been used for the treatment of a variety of non-malignant as well as malignant diseases [9].

It has also recently been the focus of considerable interest as an immunosuppressive agent, perhaps the most potent immunosuppressive drug that has been synthesized. Reports of urologic complications from this drug are haemorrhagic cystitis, vesical fibrosis and urothelial carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adiga, K. M.: Bladder tumour after treatment for lymphoma.J. Med. Austral., 190 (1981).

  2. Arnold, HI., Bourseaux, F.: Synthese und Abbau cytostatisch wirksamer zyklischer N-Phosphamidester des bis (beta-chloräthyl)-amins.Angew. Chem., 70, 539 (1958).

    Google Scholar 

  3. Brock, N., Stekar, J.: Verhütung urotoxischer Wirkungen von Cyclophosphamid und Ifosfamid durch Dimesna.Arzneim. Forsch., 32, 486 (1982).

    Google Scholar 

  4. Durkee, C., Benson, R.: Bladder cancer following administration of cyclophosphamide.Urology, 16, 145 (1980).

    PubMed  Google Scholar 

  5. Elliott, R. W., Essenhigh, D. M., Morley, A. R.: Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.Br. Med. J., 284, 1160 (1982).

    Google Scholar 

  6. Fairchild, W. V., Spence, C. R., Solomon, H. D., Gangai, M. P.: The incidence of bladder cancer after cyclophosphamide therapy.J. Urol., 122, 163 (1979).

    PubMed  Google Scholar 

  7. Fuchs, E. F., Kay, R., Poole, R., Barry, J. M., Pearse, H. D.: Uroepithelial carcinoma in association with cyclophosphamide ingestion.J. Urol., 126, 544 (1981).

    PubMed  Google Scholar 

  8. Garvin, D. D., Ball, Th. P.: Bladder malignancy in patient receiving cyclophosphamide for benign disease.Urology, 18, 80 (1981).

    PubMed  Google Scholar 

  9. Gershwin, M. E., Goetzl, E. J., Steinberg, A. D.: Cyclophosphamide: use in practice.Ann. Intern. Med., 80, 531 (1974).

    PubMed  Google Scholar 

  10. Moinuddin, S. M., Upton, D. W.: Urothelial carcinoma after cyclophosphamide therapy.J. Urol., 129, 143 (1983).

    PubMed  Google Scholar 

  11. McDougal, W. S., Cramer, S. F., Miller, R.: Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease.Cancer, 48, 691 (1981).

    PubMed  Google Scholar 

  12. Philips, F. S., Sternberg, S. S., Cronin, A. P., Vidal, P. M.: Cyclophosphamide and urinary bladder toxicity.Cancer Res., 21, 1577 (1961).

    PubMed  Google Scholar 

  13. Pearson, R. M., Soloway, M. S.: Does cyclophosphamide induce bladder cancer?Urology, 11, 437 (1978).

    PubMed  Google Scholar 

  14. Schiff, H. I., Finkel, M., Schapira, H. E.: Transitional cell carcinoma of the ureter associated with cyclophosphamide therapy for benign disease: A case report.J. Urol., 128, 1023 (1982).

    PubMed  Google Scholar 

  15. Seltzer, S. E., Benazzi, R. B., Kearney, G. P.: Cyclophosphamide and carcinoma of bladder.Urology, 11, 352 (1978).

    PubMed  Google Scholar 

  16. Worth, P. H. L.: Cyclophosphamide and the bladder.Br. Med. J., 3, 182 (1971).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiesswetter, H., Baloch, N. & Flamm, J. Bladder carcinoma following cyclophosphamide therapy. International Urology and Nephrology 17, 139–142 (1985). https://doi.org/10.1007/BF02082484

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02082484

Keywords

Navigation